Don’t miss our webinar featuring 3 in vitro diagnostics experts who have led IVD companies and clients to success. They’ll…

According to Siemens, nearly 49% of patients with elevated troponin I levels may experience a major adverse cardiac event or…

Billions of dollars will be earned by companies who can develop tests that improve the diagnosis of viral, bacterial, fungal…

With the reduction of COVID-19 testing and companies starting to recover testing revenues, there has been a tendency to say:…

hird quarter results are in at some the major in vitro diagnostic test companies. The market for IVD tests beyond…

“Arbitrary and capricious” is what the College of American Pathologists (CAP) has called the process of deciding to regulate lab-developed…

Clinical laboratories are still dealing with labor shortage issues that other industries have recovered from. Finding trained lab professionals is…

What is the market opportunity for infectious disease diagnostic tests. How will revenue opportunity for test sales grow next four…

Thanks to those who joined our EYE ON IVD State of the IVD Industry Webinar 2024 last week – with…

EYE ON IVD held its first “State of the IVD Industry 2024” webinar yesterday by introducing key topics like the…